CLINICAL_TRIALS
trial_result
· 2021-12-28
Clinical Trial Update: Long-term Safety Study of Brodalumab in Adults With Crohn's Disease [Phase 2]
Summary
A Phase 2 long-term safety study of brodalumab in adults with Crohn's disease was terminated; results were posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-12-28